This announcement is a separate document:
共同药业:2023年度董事会工作报告
Hubei Goto Biopharm: 2023 Board Work Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.